Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
MDA-MB-134-VI Senexin B
10.0
 0.91225
HCC1500 Alvocidib
0.001
 0.64032
HCC1500 MK 1775
0.1
 0.64032
MDA-MB-157 MK 1775
0.1
 0.87212
T47D Ribociclib
0.031622777
 0.97867
BT-549 RO-3306
10.0
 0.95612
MDA-MB-157 Ulixertinib
0.031622777
 0.87212
HCC1419 LY3023414
0.001
 0.96465
MDA-MB-157 Ulixertinib
1.0
 0.87212
HCC1419 AZD6738
10.0
 0.96465
HCC1500 Alvocidib
0.001
 0.64032
HCC1500 MK 1775
0.316227766017
 0.64032
MCF 10A Alvocidib
1.0
 0.99337
SK-BR-3 BMS-265246
10.0
 0.96172
HCC1500 THZ1
0.0001
 0.64032
HCC1500 Alvocidib
0.001
 0.64032
MDA-MB-436 AZD6738
10.0
 0.94793
HCC1500 AZD5363
0.001
 0.64032
HCC70 THZ1
0.1
 0.94621
HCC1954 BMS-265246
0.1
 0.93686
HCC1500 AZD6738
3.16227766017
 0.64032
HCC1500 Ulixertinib
0.001
 0.64032
CAL-120 THZ1
0.316227766017
 0.98534
HCC1500 THZ531
0.00316227766017
 0.64032
HCC1500 MK 1775
0.0316227766017
 0.64032